Anti-vascular endothelial growth factor drugs combined with laser photocoagulation maintain retinal ganglion cell integrity in patients with diabetic macular edema: study protocol for a prospective, non-randomized, controlled clinical trial

被引:1
|
作者
Li, Xiangjun [1 ]
Li, Chunyan [2 ]
Huang, Hai [2 ]
Bai, Dan [1 ]
Wang, Jingyi [1 ]
Chen, Anqi [2 ]
Gong, Yu [2 ]
Leng, Ying [1 ]
机构
[1] Beihua Univ, Affiliated Hosp, Dept Ophthalmol, Jilin, Jilin, Peoples R China
[2] Beihua Univ, Affiliated Hosp, Dept Endocrinol, Jilin, Jilin, Peoples R China
关键词
choroidal thickness; diabetic macular edema; laser photocoagulation; retinal ganglion cell-inner plexiform layer thickness; retinal ganglion cells; retinal nerve fiber layer thickness; thickness of the macular area; vascular endothelial growth factor; visual acuity; VISUAL FUNCTION; RETINOPATHY; CONBERCEPT;
D O I
10.4103/1673-5374.382104
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The integrity of retinal ganglion cells is tightly associated with diabetic macular degeneration that leads to damage and death of retinal ganglion cells, affecting vision. The major clinical treatments for diabetic macular edema are anti-vascular endothelial growth factor drugs and laser photocoagulation. However, although the macular thickness can be normalized with each of these two therapies used alone, the vision does not improve in many patients. This might result from the incomplete recovery of retinal ganglion cell injury. Therefore, a prospective, non-randomized, controlled clinical trial was designed to investigate the effect of anti-vascular endothelial growth factor drugs combined with laser photocoagulation on the integrity of retinal ganglion cells in patients with diabetic macular edema and its relationship with vision recovery. In this trial, 150 patients with diabetic macular edema will be equally divided into three groups according to therapeutic methods, followed by treatment with anti-vascular endothelial growth factor drugs, laser photocoagulation therapy, and their combination. All patients will be followed up for 12 months. The primary outcome measure is retinal ganglion cell-inner plexiform layer thickness at 12 months after treatment. The secondary outcome measures include retinal ganglion cell-inner plexiform layer thickness before and 1, 3, 6, and 9 months after treatment, retinal nerve fiber layer thickness, best-corrected visual acuity, macular area thickness, and choroidal thickness before and 1, 3, 6, 9, and 12 months after treatment. Safety measure is the incidence of adverse events at 1, 3, 6, 9, and 12 months after treatment. The study protocol hopes to validate the better efficacy and safety of the combined treatment in patients with diabetic macula compared with the other two monotherapies alone during the 12-month follow-up period. The trial is designed to focus on clarifying the time-effect relationship between imaging measures related to the integrity of retinal ganglion cells and best-corrected visual acuity. The trial protocol was approved by the Medical Ethics Committee of the Affiliated Hospital of Beihua University with approval No. (2023)(26) on April 25, 2023, and was registered with the Chinese Clinical Trial Registry (registration number: ChiCTR2300072478, June 14, 2023, protocol version: 2.0).
引用
收藏
页码:923 / 928
页数:6
相关论文
共 24 条
  • [1] Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients
    Li, Yun-Fei
    Ren, Qian
    Sun, Chao-Hui
    Li, Li
    Lian, Hai-Dong
    Sun, Rui-Xue
    Su, Xian
    Yu, Hua
    WORLD JOURNAL OF DIABETES, 2022, 13 (07) : 532 - 542
  • [2] Intravitreal anti-vascular endothelial growth factor, laser photocoagulation, or combined therapy for diabetic macular edema: A systematic review and network meta-analysis
    Chen, Jiasheng
    Wang, Haowei
    Qiu, Weiqiang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [3] Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial
    Kanar, Hatice Selen
    Arsan, Aysu
    Altun, Ahmet
    Aki, Suat Fazil
    Hacisalihoglu, Aynur
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (01) : 145 - +
  • [4] Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema Additional Efficacy Post Hoc Analyses of a Randomized Clinical Trial
    Jampol, Lee M.
    Glassman, Adam R.
    Bressler, Neil M.
    Wells, John A.
    Ayala, Allison R.
    JAMA OPHTHALMOLOGY, 2016, 134 (12) : 1429 - 1434
  • [5] Subthreshold micropulse laser combined with anti-vascular endothelial growth factor therapy for diabetic macular edema: a systematic review and meta-analysis
    Hosoya, Hironori
    Ueta, Takashi
    Hirasawa, Kazunori
    Toyama, Taku
    Shiraya, Tomoyasu
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (10) : 3073 - 3083
  • [6] Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema
    Kiss, Szilard
    Liu, Ying
    Brown, Joseph
    Holekamp, Nancy M.
    Almony, Arghavan
    Campbell, Joanna
    Kowalski, Jonathan W.
    CLINICAL OPHTHALMOLOGY, 2014, 8 : 1611 - 1621
  • [7] A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema
    Cunningham, ET Jr
    Adamis, AP
    Altaweel, M
    Aiello, LP
    Bressler, NM
    D'Amico, DJ
    Goldbaum, M
    Guyer, DR
    Katz, B
    Patel, M
    Schwartz, SD
    OPHTHALMOLOGY, 2005, 112 (10) : 1747 - 1757
  • [8] Characteristics and Treatment Patterns of Patients with Diabetic Macular Edema Non-Responsive to Anti-Vascular Endothelial Growth Factor Treatment in Ontario, Canada
    Somani, Sohel
    Koushan, Keyvan
    Shah-Manek, Bijal
    Mercer, Daniel
    Kanagenthiran, Thula
    Zhao, Changgeng
    Alobaidi, Ali
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 2013 - 2025
  • [9] Effects of Smoking on Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Patients with Diabetic Macular Edema: A Retrospective Case-Control Study
    Al Saad, Mouna
    Shehadeh, Amin
    Hizzani, Asem
    Alzibdeh, Abdulla
    Alsubhi, Amani A.
    Hamdan, Dina
    Alkubati, Ebtehal
    Meqbil, Jehad
    Hamadneh, Lina
    Ababneh, Osama
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2022, 29 (03) : 116 - 121
  • [10] Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation
    Hirano, Takao
    Toriyama, Yuichi
    Iesato, Yasuhiro
    Imai, Akira
    Hirabayashi, Kazutaka
    Nagaoka, Taiji
    Takamura, Yoshihiro
    Sugimoto, Masahiko
    Murata, Toshinori
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (01) : 51 - 60